To amend the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug if such approach satisfies the requirements of the applicable statutes and regulations.
About This Bill
Committee
Latest Action · November 12, 2020
Referred to the House Committee on Energy and Commerce.